1. Pink Sheet
  2. >>Geography
  3. >>Europe

EMA Updates GCP Guide To Clarify Sponsor Role In Contracting For Trial-Related Tasks

 
• By Vibha Sharma

Based on the trial design and setting, the European Medicines Agency says the sponsor may support the investigator by identifying or contracting service providers or personnel to be involved directly in the conduct of the clinical trial.

African doctor wear headset consult female black patient make online webcam video call on laptop screen. Telemedicine videoconference remote computer app virtual meeting. Over shoulder videocall view.
The investigator is ultimately responsible for any tasks involving trial-related medical decisions • Source: Shutterstock

The European Medicines Agency has updated its good clinical practice (GCP) guidance to support changing trends in the conduct of clinical trials, such as the increasing tendency of sponsors of decentralized clinical trials (DCTs) to get involved in contracting service providers for tasks that traditionally fall within the remit of the trial investigator.

The GCP Q&A has also been updated to address the use of productivity software in clinical trials, for example, to support operational processes and to record, track and evaluate events in a study

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

Recent and Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.

UK Health Data Research Service Looks ‘Encouraging’ For Industry, But Implementation Details Will Be Key

 
• By Anabel Costa-Ferreira

Marcus Vass and Vladimir Murovec of international law firm Osborne Clarke tell the Pink Sheet what the government's planned HDRS might mean for industry, and how it compares with the European Health Data Space.

EU Health Data Space May Speed Up R&D Through Access To Multi-Omics & Clinical Record Data

 
• By Eliza Slawther

The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.